The U.S. Food and Drug Administration (FDA) and the new health secretary, Robert F. Kennedy Jr., appear to be on a collision course over peptide injections. FDA scientists are advising against allowing widespread use of several such injections, according to a report. Kennedy, who now leads the Department of Health and Human Services, has publicly stated that people should be free to experiment with these products.
Peptides are short chains of amino acids that some people use for purposes like muscle building or anti-aging. The FDA scientists' concerns likely involve safety and lack of evidence for many uses. Kennedy, known for his skeptical views on mainstream medicine, has advocated for greater personal freedom in health choices.
The disagreement highlights a broader tension within the U.S. health system between regulatory caution and individual choice. It remains unclear what specific peptides are at issue or what steps Kennedy might take to override the scientists' advice. The FDA has not publicly commented on the matter beyond the internal advice mentioned in the report.
This clash could have significant implications for how unregulated health products are marketed and used in the future. Observers will be watching to see whether the health secretary pushes for policy changes that would relax restrictions on peptide injections.